Krystal Biotech's market cap is currently $4.41B. The company's EPS TTM is $1.767; its P/E ratio is 86.69; Krystal Biotech is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $1.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 50.70M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 47.60M	$ -4.05M	$ -2.77M	$ -1.85M	$ -974.00K
Operating Income	$ -109.73M	$ -145.20M	$ -68.28M	$ -33.00M	$ -22.08M
EBITDA	$ 17.90M	$ -145.20M	$ -65.31M	$ -30.32M	$ -18.11M
Net Income	$ 10.93M	$ -139.97M	$ -69.57M	$ -32.17M	$ -19.09M
Balance Sheet
Cash & Short-Term Investments	$ 532.18M	$ 379.17M	$ 438.10M	$ 271.26M	$ 193.69M
Total Assets	$ 818.36M	$ 558.45M	$ 626.29M	$ 310.84M	$ 209.02M
Total Debt	$ 8.09M	$ 8.93M	$ 8.02M	$ 11.55M	$ 3.26M
Net Debt	$ -350.23M	$ -152.97M	$ -333.22M	$ -256.72M	$ -184.25M
Total Liabilities	$ 39.71M	$ 36.22M	$ 32.72M	$ 18.76M	$ 6.11M
Stockholders' Equity	$ 778.64M	$ 522.23M	$ 593.58M	$ 292.08M	$ 202.91M
Cash Flow
Free Cash Flow	$ -100.60M	$ -153.55M	$ -116.27M	$ -40.93M	$ -25.11M
Operating Cash Flow	$ -88.80M	$ -100.57M	$ -47.94M	$ -26.08M	$ -18.71M
Investing Cash Flow	$ 82.64M	$ -114.08M	$ -226.77M	$ -11.18M	$ -4.97M
Financing Cash Flow	$ 202.75M	$ 35.35M	$ 347.69M	$ 118.02M	$ 107.53M

Currency in USD

Krystal Biotech Earnings and Revenue History

Income Statement >

Krystal Biotech Debt to Assets

Balance Sheet >

Krystal Biotech Cash Flow

Cash Flow >

Krystal Biotech Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing